The Gold Standard in Theranostics
BAMF Health is revolutionizing Theranostics by doing what many deemed impossible. We established the world’s first vertically integrated platform for intelligence-based precision medicine. Every day, we’re changing the lives of patients facing some of the most devastating diseases by making molecular imaging and therapy accessible and affordable.
BAMF Health's Platform
Four cutting-edge services under one roof
Molecular Imaging
Molecular Therapy
Radiopharmacy
Clinical trials
We Never Quit
We’re a team of scientists, researchers, engineers, designers, and clinicians all working in lockstep to achieve one goal—to save lives. We’re motivated by passion, empowered by collaboration, and driven to achieve the impossible.
Company Milestones
BAMF Health is founded by Anthony Chang, PhD. The company launches with three team members and begins Series A fundraising.
A groundbreaking ceremony is held at the Doug Meijer Medical Innovation Building, the future home of BAMF Health’s headquarters. Community champions and stakeholders are on hand to celebrate.
BAMF Health leaders are officially handed the keys to headquarters, and teams begin outfitting the clinic and administrative areas.
The Radiopharmacy receives critical licensing from the Nuclear Regulatory Commission (NRC) to produce radioisotopes.
The radiopharmacy celebrates its first production of solid target Ga68.
The first patient is scanned using the total-body PET/CT. This patient had been suffering from prostate cancer for more than 25 years.
Our first prostate cancer therapy dose is administered to a patient. Our first SPECT/CT scan is delivered the following day.
BAMF Health celebrates its official grand opening. In front of a crowd, Dr. Chang proclaims our mission to save millions of lives.
Our first clinical trial is initiated (ECLIPSE), offering an imaging option for those with metastatic prostate cancer.